Literature DB >> 7320439

Homologous radioimmunoassay for human mid-regional parathyroid hormone.

M J Atkinson, B Niepel, H Jüppner, R Butz, M Casaretto, H Zahn, R Hehrmann, R D Hesch.   

Abstract

A radioimmunoassay, selective for the clinically important mid region of human parathyroid hormone (hPTH), is reported. The synthetic 44-68 amino acid sequence (h44-68PTH) was used as both the standard and tracer material. This eliminated many of the undesirable characteristics associated with PTH assays the employ hormone of biological origin. These components allowed the detection of mid regional fragments present in both intact and fragmented hPTH, with a working range between 50 and 2500 pg/ml h44-68PTH. There was no interference from serum proteins and no significant cross reactivity to a range of N-terminal, C-terminal and other mid regional hPTH peptides. The assay proved to be rapid (total time 24 h) and was extremely reproducible, with an intraassay and interassay variation of 2.8% and 5.6% respectively (expressed as percentage SE in mean). The plasma concentration of normal subjects was established as 129 +/- 6 pg/ml (h44-68PTH) with a range of 50-300 pg/ml (n = 42). This assay, using fully synthetic hPTH peptides, was able to distinguish between euparathyroid and hyperparathyroid subjects, which suggests that the assay is of diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320439     DOI: 10.1007/BF03349458

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  [Calculation of radioimmunochemical determinations by "spline approximation" (author's transl)].

Authors:  H Nolte; A Mühlen; R D Hesch; J Pape; U Warnecke; H Jüppner
Journal:  J Clin Chem Clin Biochem       Date:  1976-06

Review 3.  Radioimmunoassay of human parathyroid hormone. A review with special reference to hyperparathyroidism in renal disease.

Authors:  M S Christensen
Journal:  Dan Med Bull       Date:  1979-07

Review 4.  Emerging concepts of the nature of circulating parathyroid hormones: implications for clinical research.

Authors:  E Reiss; J M Canterbury
Journal:  Recent Prog Horm Res       Date:  1974

5.  Immunochemical heterogeneity of parathyroid hormone in plasma.

Authors:  S A Berson; R S Yalow
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

6.  Human parathyroid hormone: synthesis and chemical, biological, and immunological evaluation of the carboxyl-terminal region.

Authors:  M Rosenblatt; G V Segre; G W Tregear; G L Shepard; G A Tyler; J T Potts
Journal:  Endocrinology       Date:  1978-09       Impact factor: 4.736

7.  [A highly sensitive C-terminal specific radioimmunoassay for human parathormone as a routine method (author's transl)].

Authors:  R Hehrmann; R Wilke; J P Nordmeyer; R D Hesch
Journal:  Dtsch Med Wochenschr       Date:  1976-11-19       Impact factor: 0.628

  7 in total
  7 in total

1.  [Mid C regional parathyroid hormone in the clinical workup: diagnostic value in extrarenal (primary) and renal (secondary) hyperparathyroidism].

Authors:  H Jüppner; M Atkinson; B Ringe; H P Krohn; R D Hesch
Journal:  Klin Wochenschr       Date:  1986-03-17

2.  Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.

Authors:  H Jüppner; P F Hoyer; K Latta; L Winkler; G Offner; J Brodehl
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

3.  Osteoporosis: a bone turnover defect resulting from an elevated parathyroid hormone concentration within the bone-marrow cavity?

Authors:  M J Atkinson; T Schettler; H Bodenstein; R D Hesch
Journal:  Klin Wochenschr       Date:  1984-02-01

4.  Parathyroid hormone in coronary artery disease--results of a prospective study.

Authors:  G Herrmann; R Hehrmann; H C Scholz; M Atkinson; P Lichtlen; A von zur Mühlen; R D Hesch
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

5.  Parathyroid hormone concentration gradients across the human bone marrow.

Authors:  M J Atkinson; H Bodenstein; R D Hesch
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

6.  Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.

Authors:  R D Hesch; J Heck; G Delling; E Keck; J Reeve; H Canzler; O Schober; H Harms; E F Rittinghaus
Journal:  Klin Wochenschr       Date:  1988-10-03

7.  Chlorpromazine alters bone metabolism of rats in vivo.

Authors:  T Komoda; A Nagata; M Kiyoki; M Miura; I Koyama; Y Sakagishi; M Kumegawa
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.